Skip to main content

Peer Review reports

From: Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes

Original Submission
10 Oct 2016 Submitted Original manuscript
2 Apr 2017 Reviewed Reviewer Report - Eric A Finkelstein
6 Jun 2017 Reviewed Reviewer Report - Eugenia Amporfu
7 Jun 2017 Reviewed Reviewer Report - Charles Ezenduka
27 Jun 2017 Author responded Author comments - Christina Kwon
Resubmission - Version 2
27 Jun 2017 Submitted Manuscript version 2
24 Jul 2017 Reviewed Reviewer Report - Eric A Finkelstein
31 Jul 2017 Reviewed Reviewer Report - Charles Ezenduka
24 Aug 2017 Author responded Author comments - Christina Kwon
Resubmission - Version 3
24 Aug 2017 Submitted Manuscript version 3
17 Dec 2017 Author responded Author comments - Christina Kwon
Resubmission - Version 4
17 Dec 2017 Submitted Manuscript version 4
Publishing
18 Jan 2018 Editorially accepted
1 Feb 2018 Article published 10.1186/s12913-018-2860-0

You can find further information about peer review here.

Back to article page